[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
November 1994

Release of Markedly Increased Quantities of Prostaglandin D2 From the Skin In Vivo in Humans Following the Application of Sorbic Acid

Arch Dermatol. 1994;130(11):1408-1412. doi:10.1001/archderm.1994.01690110074010

Background and Design:  Sorbic acid is a preservative that can induce cutaneous vasodilation characterized by erythema, urticaria, and stinging when applied topically to humans. Previous studies have suggested that prostaglandins may mediate the vasodilation, but the prostaglandin responsible has not been established. Recently, we have shown that cutaneous erythema similar to that associated with the application of sorbic acid is induced by topical administration of methylnicotinate and is mediated by the release of prostaglandin D2 (PGD2) from the skin. Therefore, we examined whether the cutaneous vasodilation induced by sorbic acid is also mediated by this prostaglandin in humans.

Results:  Topical application of 1% sorbic acid to the forearms of four human volunteers resulted in 250- to 620- fold increases in levels of PGD2 and 15- to 58-fold increases in levels of the metabolite of PGD2, 9α,11β-PGF2, in blood drawn from the antecubital vein draining the treated sites. There were no increases in the release of the other vasodilatory prostaglandins, PGE2 or prostacyclin (PGI2). The release of PGD2 in response to topically applied sorbic acid occurred in a dose-dependent manner and was not accompanied by a release of histamine, suggesting that the release of PGD2 was not from the mast cell.

Conclusions:  The cutaneous vasodilation that occurs following the administration of sorbic acid is primarily due to a release of PGD2 from a cellular source in the skin.(Arch Dermatol. 1994;130:1408-1412)